{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:06:41Z","timestamp":1786990001291,"version":"build-2736575974"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T00:00:00Z","timestamp":1624492800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Growth Hormone & IGF Research"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.ghir.2021.101389","type":"journal-article","created":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T00:40:03Z","timestamp":1619743203000},"page":"101389","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Economic and clinical burden of comorbidities among patients with acromegaly"],"prefix":"10.1016","volume":"59","author":[{"given":"Melanie D.","family":"Whittington","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn A.","family":"Munoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Whalen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Ribeiro-Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan D.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ghir.2021.101389_bb0005","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s11102-016-0754-x","article-title":"Epidemiology of acromegaly: review of population studies","volume":"20","author":"Lavrentaki","year":"2017","journal-title":"Pituitary."},{"issue":"24","key":"10.1016\/j.ghir.2021.101389_bb0010","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1056\/NEJMra062453","article-title":"Acromegaly","volume":"355","author":"Melmed","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.ghir.2021.101389_bb0015","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/s41574-018-0058-5","article-title":"A consensus statement on acromegaly therapeutic outcomes","volume":"14","author":"Melmed","year":"2018","journal-title":"Nat Rev Endocrinol."},{"issue":"1","key":"10.1016\/j.ghir.2021.101389_bb0020","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s11102-016-0772-8","article-title":"Acromegaly: clinical features at diagnosis","volume":"20","author":"Vilar","year":"2017","journal-title":"Pituitary."},{"issue":"6","key":"10.1016\/j.ghir.2021.101389_bb0025","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1530\/EJE-18-0925","article-title":"Patients\u2019 perspectives on acromegaly diagnostic delay: a qualitative study","volume":"180","author":"Sibeoni","year":"2019","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"10.1016\/j.ghir.2021.101389_bb0030","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12902-017-0166-6","article-title":"The association between biochemical control and cardiovascular risk factors in acromegaly","volume":"17","author":"Carmichael","year":"2017","journal-title":"BMC Endocr. Disord."},{"key":"10.1016\/j.ghir.2021.101389_bb0035","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.2147\/PPA.S102302","article-title":"Clinical importance of achieving biochemical control with medical therapy in adult patients with acromegaly","volume":"10","author":"Christofides","year":"2016","journal-title":"Patient Prefer Adherence."},{"issue":"3","key":"10.1016\/j.ghir.2021.101389_bb0040","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s11102-011-0310-7","article-title":"Clinical, quality of life, and economic value of acromegaly disease control","volume":"14","author":"Ben-Shlomo","year":"2011","journal-title":"Pituitary."},{"issue":"7","key":"10.1016\/j.ghir.2021.101389_bb0045","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1056\/NEJMoa1800256","article-title":"Risk factors, mortality, and cardiovascular outcomes in patients with type 2 diabetes","volume":"379","author":"Rawshani","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ghir.2021.101389_bb0050","doi-asserted-by":"crossref","first-page":"9418","DOI":"10.1038\/s41598-018-27377-2","article-title":"Uncontrolled hypertension increases risk of all-cause and cardiovascular disease mortality in US adults: the NHANES III linked mortality study","volume":"8","author":"Zhou","year":"2018","journal-title":"Sci. Rep."},{"issue":"Supplement_1","key":"10.1016\/j.ghir.2021.101389_bb0055","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsz067.502","article-title":"0504 Mortality risk associated with mild-to-moderate sleep apnea is modified by age","volume":"42","author":"Vgontzas","year":"2019","journal-title":"Sleep"},{"key":"10.1016\/j.ghir.2021.101389_bb0060","author":"Pennsylvania Department of Health"},{"issue":"11","key":"10.1016\/j.ghir.2021.101389_bb0065","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1007\/BF03345306","article-title":"Cost-of-illness study in acromegalic patients in Italy","volume":"27","author":"Didoni","year":"2004","journal-title":"J. Endocrinol. Investig."},{"issue":"12","key":"10.1016\/j.ghir.2021.101389_bb0070","first-page":"1106","article-title":"Clinical and economic burden of commercially insured patients with acromegaly in the United States: a retrospective analysis","volume":"21","author":"Placzek","year":"2015","journal-title":"J Manag Care Spec Pharm."},{"key":"10.1016\/j.ghir.2021.101389_bb0075","author":"Centers for Disease Control and Prevention"},{"key":"10.1016\/j.ghir.2021.101389_bb0080","author":"Centers for Disease Control and Prevention"},{"key":"10.1016\/j.ghir.2021.101389_bb0085","author":"Centers for Disease Control and Prevention"},{"key":"10.1016\/j.ghir.2021.101389_bb0090","author":"National Cancer Institute"},{"issue":"1","key":"10.1016\/j.ghir.2021.101389_bb0095","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1164\/ajrccm.157.1.9706079","article-title":"Effects of age on sleep apnea in men: I. prevalence and severity","volume":"157","author":"Bixler","year":"1998","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"3 Pt 1","key":"10.1016\/j.ghir.2021.101389_bb0100","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1164\/ajrccm.163.3.9911064","article-title":"Prevalence of sleep-disordered breathing in women: effects of gender","volume":"163","author":"Bixler","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ghir.2021.101389_bb0105","author":"Smith"},{"issue":"4","key":"10.1016\/j.ghir.2021.101389_bb0110","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1210\/jc.2012-4059","article-title":"Deaths among adult patients with hypopituitarism: hypocortisolism during acute stress, and de novo malignant brain tumors contribute to an increased mortality","volume":"98","author":"Burman","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.ghir.2021.101389_bb0115","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1177\/0272989X06290495","article-title":"Preference-based EQ-5D index scores for chronic conditions in the United States","volume":"26","author":"Sullivan","year":"2006","journal-title":"Med. Decis. Mak."},{"issue":"3","key":"10.1016\/j.ghir.2021.101389_bb0120","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s11136-010-9589-5","article-title":"Preference values associated with stage III colon cancer and adjuvant chemotherapy","volume":"19","author":"Best","year":"2010","journal-title":"Qual. Life Res."},{"issue":"4","key":"10.1016\/j.ghir.2021.101389_bb0125","doi-asserted-by":"crossref","first-page":"149P","DOI":"10.1378\/chest.134.4_MeetingAbstracts.p149001","article-title":"Utility indices in obstructive sleep apnea patients","volume":"134","author":"Bloch","year":"2008","journal-title":"Chest."},{"issue":"4","key":"10.1016\/j.ghir.2021.101389_bb0130","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s11102-013-0506-0","article-title":"Treatments, complications, and healthcare utilization associated with acromegaly: a study in two large United States databases","volume":"17","author":"Broder","year":"2014","journal-title":"Pituitary."},{"issue":"1","key":"10.1016\/j.ghir.2021.101389_bb0135","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s12020-018-1615-3","article-title":"Screening for comorbid conditions in patients enrolled in the SODA registry: a 2-year observational analysis","volume":"61","author":"Woodmansee","year":"2018","journal-title":"Endocrine."},{"issue":"3","key":"10.1016\/j.ghir.2021.101389_bb0140","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s40801-015-0039-0","article-title":"Treatment patterns and economic burden in patients treated for acromegaly in the USA","volume":"2","author":"Chuang","year":"2015","journal-title":"Drugs - Real World Outcomes."}],"container-title":["Growth Hormone & IGF Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637421000125?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637421000125?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T22:52:30Z","timestamp":1761087150000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096637421000125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":28,"alternative-id":["S1096637421000125"],"URL":"https:\/\/doi.org\/10.1016\/j.ghir.2021.101389","relation":{},"ISSN":["1096-6374"],"issn-type":[{"value":"1096-6374","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Economic and clinical burden of comorbidities among patients with acromegaly","name":"articletitle","label":"Article Title"},{"value":"Growth Hormone & IGF Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ghir.2021.101389","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101389"}}